Biodexa Pharmaceuticals Plc - ADR
BDRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$647.7K
Close$
$0.02
97.4% downside
Current Fair Value
97.4% downsideOvervalued by 97.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $647,701.00 |
|---|---|
| Enterprise Value | $-7,810,406.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-400 |
| Beta | 1.24 |
| Outstanding Shares | 90,327 |
Return
| Return on Equity | -91.73% |
|---|---|
| Return on Assets | -57.55% |
| Return on Invested Capital | -131.59% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | -0.02 |
| Price to Sales | - |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.49 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
April 24, 2026
EPS Estimate
$-0.00
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
September 11, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Biodexa Pharmaceuticals Plc
20 employees